- Home
- ORGO vs PML Comparison
ORGO vs PML Comparison
Compare ORGO & PML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- PML
- Stock Information
- Founded
- ORGO 1985
- PML 2002
- Country
- ORGO United States
- PML United States
- Employees
- ORGO N/A
- PML N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- PML Investment Managers
- Sector
- ORGO Health Care
- PML Finance
- Exchange
- ORGO Nasdaq
- PML Nasdaq
- Market Cap
- ORGO 665.8M
- PML 570.5M
- IPO Year
- ORGO N/A
- PML N/A
- Fundamental
- Price
- ORGO $4.28
- PML $8.13
- Analyst Decision
- ORGO Buy
- PML
- Analyst Count
- ORGO 2
- PML 0
- Target Price
- ORGO $5.50
- PML N/A
- AVG Volume (30 Days)
- ORGO 1.3M
- PML 188.0K
- Earning Date
- ORGO 05-08-2025
- PML 01-01-0001
- Dividend Yield
- ORGO N/A
- PML 5.65%
- EPS Growth
- ORGO N/A
- PML N/A
- EPS
- ORGO N/A
- PML N/A
- Revenue
- ORGO $482,043,000.00
- PML N/A
- Revenue This Year
- ORGO N/A
- PML N/A
- Revenue Next Year
- ORGO $7.62
- PML N/A
- P/E Ratio
- ORGO N/A
- PML N/A
- Revenue Growth
- ORGO 11.29
- PML N/A
- 52 Week Low
- ORGO $2.17
- PML $6.92
- 52 Week High
- ORGO $6.71
- PML $9.46
- Technical
- Relative Strength Index (RSI)
- ORGO 43.72
- PML 39.91
- Support Level
- ORGO $4.80
- PML $8.01
- Resistance Level
- ORGO $5.57
- PML $8.21
- Average True Range (ATR)
- ORGO 0.32
- PML 0.08
- MACD
- ORGO -0.15
- PML -0.01
- Stochastic Oscillator
- ORGO 3.73
- PML 48.04
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About PML Pimco Municipal Income Fund II of Beneficial Interest
PIMCO Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as education, healthcare, and others.